Hong Kong-based Aptorum Therapeutics, currently in the pre-clinical phase of development, focuses on finding cures for rare diseases, also known as “orphan diseases”. Its founder Ian Huen says the company combines big data with artificial intelligence to analyse whether drugs already in the market can be used to treat rare diseases. It also works with local universities in the hope of taking healthcare to a new level in the history of medicine.
Flussig Medtech's VP Louis Sze was a university researcher before applying his entrepreneurial skills to 3D printing, initially for orthopaedic solutions. Since then, he has extended applications to precision medicine covering coronary, brain and plastic surgeries. He says that medical 3D printing is not all about hardware, but also how to make use of data to conduct high-quality medical imaging.
Dr. Langston Suen, Founder & CEO of Opharmic Technology
Many patients are put off by traditional ways of treating eye diseases involving an injection into their eye and a lengthy wait for dilated pupils to return to normal so they can resume simple tasks such as driving. After more than eight years of research, Opharmic's Founder & CEO Langston Suen and his mentor have invented an ultrasonic solution for non-invasive ocular drug delivery. It’s not only great news for patients, it also opens a window to revolutionising ocular medical care.